Alpha Dna Investment Management LLC Xencor Inc Transaction History

Alpha Dna Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$20.08 - $25.39 $563,746 - $712,824	28,075 New	28,075 $565,000
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $891,813 - $1.31 Million	-45,178 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $1.21 Million - $1.88 Million	45,178 New	45,178 $1.2 Million
Q2 2021 Aug 10, 2021	SELL	$34.33 - $44.68 $2,403 - $3,127	-70 Closed	0 $0
Q4 2020 Mar 24, 2021	BUY	$36.63 - $47.63 $2,564 - $3,334	70 New	70 $3,000

216

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.